Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Canadian Natural Resources Ltd. (CNQ) vs ResMed Inc. (RMD) Price & Performance

Canadian Natural Resources Ltd.Trade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

Canadian Natural Resources Ltd. vs ResMed Inc. — how do they compare? Canadian Natural Resources Ltd. trades at $47.72 (market cap $98.11B), while ResMed Inc. trades at $226.37 (market cap $32.61B). The key difference: Canadian Natural Resources Ltd. is far larger — about 3× ResMed Inc.'s market cap, and Canadian Natural Resources Ltd. pays the higher dividend (3.73%). Which is the better fit depends on your goals.

CNQRMD
Market Cap
$98.11B$32.61B
Sector
EnergyHealth
52-Week High
$50.55$293.73
52-Week Low
$29.31$182.82
Enterprise Value
$108.54B$31.97B
Dividend Yield
3.73%1.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Canadian Natural Resources Ltd.

Canadian Natural Resources (CNQ) trades at $47.845, up 1.26% today, with a bullish technical signal and strong earnings momentum after Q2 2026 EPS beat estimates. The company shows robust profitability with a 22.87% net margin and 26.69% ROE, supported by record production and disciplined capital spending. Recent news highlights dividend reliability and operational strength, with analyst consensus heavily favoring buy ratings.

CNQ presents a compelling investment case with attractive valuation (P/E 11.82), consistent dividend payouts, and positive cash flow trends. Key risks include oil price volatility and rising debt levels, but the company's scale and efficiency underpin resilience. Wall Street optimism, with 27 buy ratings, suggests further upside potential amid stable energy demand.

ResMed Inc.

ResMed (RMD) trades at $225.17, up 2.33% today, reflecting strong recent earnings beats and robust fundamentals. The stock exhibits a bullish technical trend, supported by positive moving averages, with key resistance near $227. Financially, the company shows impressive growth, with Q4 2026 revenue reaching a record $1.5 billion (Reuters, 2026-08-07) and a net income margin of 26.94%. Recent strategic moves include the divestiture of the MatrixCare business to sharpen focus on core sleep and respiratory care markets.

The outlook for RMD is positive, driven by consistent earnings outperformance and strategic portfolio optimization. However, investors face risks from weaker-than-expected fiscal 2027 revenue guidance and competitive pressures in the medtech sector. The consensus price target of $235.00 (MarketBeat, 2026-08-09) suggests modest upside potential, supported by a majority analyst hold rating amid solid long-term growth prospects.

Returns comparison

Trailing returns across standard periods

About Canadian Natural Resources Ltd.

Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.

Read more on CNQ

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD